| 前收市價 | 1.0500 |
| 開市 | 1.9200 |
| 買盤 | 0.9500 |
| 賣出價 | 1.2500 |
| 拍板 | 12.50 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 1.9200 - 1.9200 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 403 |
Insider MonkeySage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript April 25, 2024 Sage Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.8 EPS, expectations were $-1.63. Sage Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
ZacksSage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.
ZacksSage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates
Sage Therapeutics (SAGE) delivered earnings and revenue surprises of -10.43% and 28.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
